Demonstrates how nanoparticles influence alpha-synuclein aggregation, suggesting new therapeutic targets.
Nanoplastics and engineered nanoparticles interact in varying ways with amyloidogenic proteins, yet the mechanistic basis for the pathological effects caused by that interplay remains unclear. Here, we demonstrate how carboxylated...
No takes yet. Share an insight, caveat, or question.
Zanganeh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: